Mankind Pharma Limited (BOM:543904)
2,660.00
+30.00 (1.14%)
At close: Nov 20, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.1 trillion as of November 20, 2026. Its market cap has increased by 19.96% in one year.
Market Cap
1.10T
Enterprise Value
1.13T
Revenue
153.79B
Global Rank
n/a
Country Rank
n/a
PE Ratio
49.04
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.10T, an increase of 93.20%. That is a compound annual growth rate of 20.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.10T | 21.40% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.24T |
| Zydus Lifesciences | 1.20T |
| Cipla | 1.14T |
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 747.32B |
| Alkem Laboratories | 619.94B |
| Gland Pharma | 549.34B |